UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance

Cancers, 2021-09, Vol.13 (19), p.4820

2021

Volltextzugriff (PDF)

Acute myeloid leukemia in the older adults

Leukemia research reports, 2016, Vol.6 (C), p.1-7

2016

Volltextzugriff (PDF)

MicroRNA signature refine response prediction in CML

Scientific reports, 2019-07, Vol.9 (1), p.9666-10, Article 9666

2019

Volltextzugriff (PDF)

Genetic Variants of ABC and SLC Transporter Genes and Chronic Myeloid Leukaemia: Impact on Susceptibility and Prognosis

International journal of molecular sciences, 2022-09, Vol.23 (17), p.9815

2022

Volltextzugriff (PDF)

First tonic-clonic seizure five hours after Ad26.COV2.S vaccination without acute brain lesion but long-term chorea

Clinics (São Paulo, Brazil), 2023-01, Vol.78, p.100281, Article 100281

2023

Volltextzugriff (PDF)

The Activation of Endothelial Cells Relies on a Ferroptosis-Like Mechanism: Novel Perspectives in Management of Angiogenesis and Cancer Therapy

Frontiers in oncology, 2021-05, Vol.11, p.656229-656229

2021

Volltextzugriff (PDF)

MORPhA Scale: Behavioral and electroencephalographic validation of a rodent anesthesia scale

Journal of neuroscience methods, 2019-08, Vol.324, p.108304-108304, Article 108304

2019

Volltextzugriff (PDF)

Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-α

Journal of translational medicine, 2020-01, Vol.18 (1), p.2-2, Article 2

2020

Volltextzugriff (PDF)

Combination of Elacridar with Imatinib Modulates Resistance Associated with Drug Efflux Transporters in Chronic Myeloid Leukemia

Biomedicines, 2022-05, Vol.10 (5), p.1158

2022

Volltextzugriff (PDF)

The Bone Marrow-Mediated Protection of Myeloproliferative Neoplastic Cells to Vorinostat and Ruxolitinib Relies on the Activation of JNK and PI3K Signalling Pathways

PloS one, 2015-12, Vol.10 (12), p.e0143897-e0143897

2015

Volltextzugriff (PDF)

Monocytes as Endothelial Progenitor Cells (EPCs), Another Brick in the Wall to Disentangle Tumor Angiogenesis

Cells (Basel, Switzerland), 2020-01, Vol.9 (1), p.107

2020

Volltextzugriff (PDF)

Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients

Haematologica (Roma), 2017-03, Vol.102 (3), p.e76-e79

2017

Volltextzugriff (PDF)

Vorinostat synergizes with antioxidant therapy to target myeloproliferative neoplasms

Experimental hematology, 2019-04, Vol.72, p.60-71.e11

2019

Volltextzugriff (PDF)

Everolimus in combination with Imatinib overcomes resistance in Chronic myeloid leukaemia

Medical oncology (Northwood, London, England), 2019-03, Vol.36 (3), p.30-10, Article 30

2019

Volltextzugriff (PDF)

Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency

Nature medicine, 2006-07, Vol.12 (7), p.846-851

2006

Volltextzugriff (PDF)

PPARα Gene Is Involved in Body Composition Variation in Response to an Aerobic Training Program in Overweight/Obese

PPAR research, 2021, Vol.2021, p.1-9

2021

Volltextzugriff (PDF)

Less iron improves MDS haematopoiesis

British journal of haematology, 2019-10, Vol.187 (1), p.11-12

2019

Volltextzugriff (PDF)

HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?

Oncotarget, 2017-04, Vol.8 (17), p.28187-28202

2017

Volltextzugriff (PDF)

Redox properties of (1-(2-pyridylazo)-2-naphthol)copper(II) encapsulated in Y Zeolite

Microporous and mesoporous materials, 2009, Vol.117 (1), p.297-303

2009

Volltextzugriff (PDF)

Static Hand Gesture Recognition Based on Convolutional Neural Networks

Journal of Electrical and Computer Engineering, 2019, Vol.2019 (2019), p.1-12

2019

Volltextzugriff (PDF)

Before Blaming Legionella for Severe Rhabdomyolysis, Consider Alternative Triggers

Journal of community hospital internal medicine perspectives, 2023-01, Vol.13 (1), p.58-59

2023

Volltextzugriff (PDF)

The European Hematology Exam: The Next Step toward the Harmonization of Hematology Training in Europe

HemaSphere, 2019-10, Vol.3 (5), p.1-5

2019

Volltextzugriff (PDF)

Optimizing treatments in rare diseases: Will our evidence come from registry data?

Leukemia research, 2014-04, Vol.38 (4), p.421-422

Almeida, Antonio M

2014

Volltextzugriff (PDF)

1 – 25 von 2.282

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.888)
Mit Volltextzugriff
(2.012)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.455)
Life Sciences & Biomedicine
(1.023)
Humans
(575)
Male
(374)
Female
(373)
Technology
(305)
Animals
(250)
Physical Sciences
(239)
Adult
(223)
Middle Aged
(204)
Biological And Medical Sciences
(170)
Chemistry
(134)
Engineering
(131)
Medical Sciences
(129)
Aged
(126)
Computer Science
(107)
Brazil
(105)
Science & Technology - Other Topics
(104)
Pharmacology & Pharmacy
(102)
Adolescent
(101)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(25)
... seit 30 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance

Acute myeloid leukemia in the older adults

MicroRNA signature refine response prediction in CML

Genetic Variants of ABC and SLC Transporter Genes and Chronic Myeloid Leukaemia: Impact on Susceptibility and Prognosis

First tonic-clonic seizure five hours after Ad26.COV2.S vaccination without acute brain lesion but long-term chorea

The Activation of Endothelial Cells Relies on a Ferroptosis-Like Mechanism: Novel Perspectives in Management of Angiogenesis and Cancer Therapy

MORPhA Scale: Behavioral and electroencephalographic validation of a rodent anesthesia scale

Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-α

Combination of Elacridar with Imatinib Modulates Resistance Associated with Drug Efflux Transporters in Chronic Myeloid Leukemia

The Bone Marrow-Mediated Protection of Myeloproliferative Neoplastic Cells to Vorinostat and Ruxolitinib Relies on the Activation of JNK and PI3K Signalling Pathways

Monocytes as Endothelial Progenitor Cells (EPCs), Another Brick in the Wall to Disentangle Tumor Angiogenesis

Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients

Vorinostat synergizes with antioxidant therapy to target myeloproliferative neoplasms

Everolimus in combination with Imatinib overcomes resistance in Chronic myeloid leukaemia

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+)

Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency

PPARα Gene Is Involved in Body Composition Variation in Response to an Aerobic Training Program in Overweight/Obese

Less iron improves MDS haematopoiesis

HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?

Redox properties of (1-(2-pyridylazo)-2-naphthol)copper(II) encapsulated in Y Zeolite

Static Hand Gesture Recognition Based on Convolutional Neural Networks

Before Blaming Legionella for Severe Rhabdomyolysis, Consider Alternative Triggers

The European Hematology Exam: The Next Step toward the Harmonization of Hematology Training in Europe

Validation of the revised international prognostic scoring system (IPSS‐R) in patients with lower‐risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry

Optimizing treatments in rare diseases: Will our evidence come from registry data?

Suchergebnisse filtern